Targeting the anthrax receptors, TEM-8 and CMG-2, for anti-angiogenic therapy

Por Cryan, Lorna M., Rogers, Michael S.
Publicado em 2011

1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose (PGG) Inhibits Angiogenesis via Inhibition of CMG2

Por Cryan, Lorna M., Bazinet, Lauren, Habeshian, Kaiane A., Cao, Shugeng, Clardy, Jon, Christensen, Kenneth A., Rogers, Michael S.
Publicado em 2013

Proteomics Strategy for Identifying Candidate Bioactive Proteins in Complex Mixtures: Application to the Platelet Releasate

Por O'Connor, Roisin, Cryan, Lorna M., Wynne, Kieran, de Stefani, Andreas, Fitzgerald, Desmond, O'Brien, Colm, Cagney, Gerard
Publicado em 2010

A FRET-Based High Throughput Screening Assay to Identify Inhibitors of Anthrax Protective Antigen Binding to Capillary Morphogenesis Gene 2 Protein

Por Rogers, Michael S., Cryan, Lorna M., Habeshian, Kaiane A., Bazinet, Lauren, Caldwell, Thomas P., Ackroyd, P. Christine, Christensen, Kenneth A.
Publicado em 2012

Identification of small molecules that inhibit the interaction of TEM8 with anthrax protective antigen using a FRET assay

Por Cryan, Lorna M., Habeshian, Kaiane A., Caldwell, Thomas P., Morris, Meredith T., Ackroyd, P. Christine, Christensen, Kenneth A., Rogers, Michael S.
Publicado em 2013